Harris v. Amgen, Inc.

573 F.3d 728, 47 Employee Benefits Cas. (BNA) 1332, 2009 U.S. App. LEXIS 15499, 2009 WL 2020785
CourtCourt of Appeals for the Ninth Circuit
DecidedJuly 14, 2009
Docket08-55389
StatusPublished
Cited by181 cases

This text of 573 F.3d 728 (Harris v. Amgen, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Harris v. Amgen, Inc., 573 F.3d 728, 47 Employee Benefits Cas. (BNA) 1332, 2009 U.S. App. LEXIS 15499, 2009 WL 2020785 (9th Cir. 2009).

Opinion

OPINION

GOULD, Circuit Judge:

Steve Harris and Dennis F. Ramos (collectively, “Plaintiffs”) sued Amgen, Inc. (“Amgen”) and several Amgen directors and officers, alleging that the defendants breached their fiduciary duties under the Employee Retirement Income Security Act (“ERISA”) in their operation of two ERISA retirement plans. The district court dismissed Harris’s claims on the ground that he lacked standing as an ERISA plan “participant” because he had withdrawn all of his assets from his plan. It also dismissed Ramos’s claims, reasoning that although Ramos had standing, he did not allege any claims against defendants who were fiduciaries under the plan. The district court then denied Plaintiffs leave to amend their complaint.

We reverse the dismissal of Plaintiffs’ complaint. We hold that Harris has standing as an ERISA plan participant to seek relief under ERISA § 502(a)(2), codified at 29 U.S.C. § 1132(a)(2), despite having withdrawn all of his assets from his plan. We also conclude that the district court improperly denied Plaintiffs leave to amend their complaint to add more factual allegations where necessary and to identify proper fiduciaries of the Plaintiffs’ ERISA plans.

I

Amgen is a publicly traded biotechnology company that operates Amgen Manufacturing, Ltd. (“Amgen Manufacturing”) as a wholly owned subsidiary. Employees of Amgen are entitled to participate in the Amgen Retirement and Savings Plan (the “Amgen Plan”), and Amgen Manufacturing employees may participate in the Retirement and Savings Plan for Amgen Manufacturing, Ltd. (the “Manufacturing Plan”). Each Plan is a “defined contribution plan,” defined as “a pension plan which provides for an individual account for each participant and for benefits based solely upon the amount contributed to the participant’s account.” 29 U.S.C. § 1002(34). 1

Amgen is a “named fiduciary” only of the Amgen Plan, 2 and Amgen Manufacturing is a named fiduciary only of the Manufacturing Plan. The Amgen Plan allows the Amgen Board of Directors (the “Board”) to delegate management and administration of the Plan to a “Fiduciary Committee.” During the time relevant to this appeal, fiduciary responsibilities for both Plans were delegated to the Fiduciary Committee.

Steve Harris worked at Amgen until January 2007 and participated in the Am-gen Plan. His Amgen Plan holdings sometimes included Amgen stock. Harris withdrew his assets from his Amgen Plan account in July 2007. Dennis F. Ramos worked at Amgen Manufacturing until March 2007, participating in the Manufacturing Plan. His Manufacturing Plan holdings also sometimes included Amgen Stock. Ramos still has assets in the Manufacturing Plan.

In August 2007 Harris and Ramos filed a class action complaint (the “Complaint”), alleging that during a 22-month class peri *732 od the defendants breached their fiduciary duties by allowing the Plans to purchase and hold Amgen stock while knowing, that the stock price was artificially inflated because of improper off-label drug marketing and sales. The Complaint asserts that the Amgen stock price declined significantly once the off-label activity became public, and Harris and Ramos- claim that the defendants are liable for the resulting losses suffered by the class members. The Complaint sought relief under ERISA § 502(a)(2) (“Section 502(a)(2)”), codified at 29 U.S.C. § 1132(a)(2), which authorizes a suit by a plan participant “for appropriate relief’ against a plan fiduciary for breach of fiduciary duty.

The Complaint names as defendants Amgen, Amgen’s chief financial officer, and nine Amgen Board members (collectively, “Defendants”). Neither Amgen Manufacturing nor the Fiduciary Committee is named as a defendant! However, the Complaint does assert claims against a “Retirement Benefits Committee of the Board of Directors of Amgen,” which it claims has fiduciary responsibilities over both Plans.

Defendants filed a motion to dismiss for lack of subject matter jurisdiction under Federal Rule of Civil Procedure (“Rule”) 12(b)(1), and for failure to state a claim under Rule 12(b)(6). The district court granted the motion and dismissed with prejudice all of Harris’s claims, concluding that Harris did not have statutory standing as a “participant” in the Amgen Plan because he had already cashed out of his Plan account. The district court determined that Ramos had standing because he still had assets in the Manufacturing Plan, but it dismissed with prejudice all of Ramos’s claims on the ground that neither Amgen, the alleged retirement committee, nor the named defendants were fiduciaries of the Manufacturing Plan.

The district court also denied Plaintiffs’ request for leave to amend their Complaint. The district court reasoned that Harris could not cure his lack of standing through amendment and that Ramos did not “have a viable claim against the named defendants.” The district court expressly made “no determination as to whether Plaintiffs have a viable claim against Am-gen Manufacturing or the members of the Fiduciary Committee.” Harris and Ramos appeal the dismissal of their claims and-the denial of leave to amend.

II

A

We first consider whether the district court properly determined that Harris lacked standing under Section 502(a)(2) because he had withdrawn his assets from the Amgen Plan. We review questions of standing under ERISA de novo. Stewart v. Thorpe Holding Co. Profit Sharing Plan, 207 F.3d 1143, 1148 (9th Cir.2000). 3

“To establish standing to sue under ERISA, [plaintiffs] must show that they are plan ‘participants.’ ” Poore v. Simpson Paper Co., 566 F.3d 922, 925 (9th Cir.2009). Plaintiffs seek relief under Section 502(a)(2), which grants standing to a plan participant to bring an action against a defendant who breaches a fiduciary duty *733 with respect to that plan. See 29 U.S.C. § 1132(a)(2). An ERISA plan participant is “any employee or former employee of an employer ... who is or may become eligible to receive a benefit of any type from an employee benefit plan which covers employees of such employer.... ” 29 U.S.C. § 1002(7). This definition encompasses “former employees who have ... a color-able claim to vested benefits.” Firestone Tire & Rubber Co. v. Bruch, 489 U.S. 101, 117, 109 S.Ct.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
573 F.3d 728, 47 Employee Benefits Cas. (BNA) 1332, 2009 U.S. App. LEXIS 15499, 2009 WL 2020785, Counsel Stack Legal Research, https://law.counselstack.com/opinion/harris-v-amgen-inc-ca9-2009.